Latest Biomarker Stories
LONDON, March 30, 2015 /PRNewswire/ -- REPORT HIGHLIGHTSThe in vitro diagnostic renal biomarker market was valued at $771 million in 2013 and $812 million in 2014.
According to a new study in the journal Nature, researchers at the National Institute of Standards and Technology (NIST) and the National Institutes of Health (NIH) are developing a system capable of delivering high-resolution data while penetrating deep into the body.
Multi-Disciplinary Guidance Document Focuses on Using Molecular Markers to Optimize Patient Care CHICAGO and NORTHFIELD, Ill. and BETHESDA, Md.
Study Results Featured in Plenary Session at Society of Gynecologic Oncology Annual Meeting IRVING, Texas, March 30, 2015 /PRNewswire/ -- Caris Life Sciences® today announced the
Research Presented at the Society of Gynecologic Oncology 2015 Annual Meeting Suggest Treatment Options Based on Biomarker Profile May Result in Improved Outcomes IRVING, Texas, March
Research Provides Potential Implications for Immunotherapy in Treatment of Gynecologic Cancers IRVING, Texas, March 29, 2015 /PRNewswire/ -- Caris Life Sciences® today announced the
Study Results Highlight Molecular Similarities and Differences between Uterine Papillary and Ovarian Serous Carcinomas, and between Epithelial Ovarian and Endometrial Cancers IRVING,
LA JOLLA, Calif., March 25, 2015 /PRNewswire/ -- Regulus Therapeutics Inc.
PPMI now recruiting individuals with genetic mutation linked to Gaucher disease NEW YORK, March 24, 2015 /PRNewswire-USNewswire/ -- The Parkinson's Progression Markers Initiative (PPMI),
UK scientists say some markers are better than others for predicting mesothelioma prognosis and monitoring treatment response. Raleigh, NC (PRWEB) March 19,
- Large; stout; burly.
More Images (2 images) »